Overall, the main stocks are strong in the market.

Emerging markets rose significantly this week. While the Nikkei Average rose +0.79%, the growth market index rose +4.63% and the growth market 250 index rose +5.16%, highlighting the rise of the emerging market. Similar to the prime market, although the trading volume has not expanded significantly, the market sentiment has improved, leading to overall strength in large-cap stocks such as the core constituents of the growth market index. The growth market 250 index returned to the level of August 1st at the opening price (641.96 points).

Among the top market capitalization stocks, JTOWER <4485> pushed the price closer to 3600 yen in a tender offer, and GENDA <9166> updated its all-time high after a series of 12 consecutive rises due to feature coverage in some media. AstroScale HD <186A> announced that its consolidated subsidiary has signed a large-scale contract with the Japan Aerospace Exploration Agency (JAXA) for the Commercial Removal of Debris (CRD2) Phase II, which led to buying. In other stocks, SBI Leos Himi <165A> was also bought based on stock splits and dividend estimates, while bio-related stocks such as AnGes <4563>, Shionogi Pharma <4582>, and Cellseed <7776> were buzzing. On the other hand, stocks with double-digit stock prices such as Flutafurta <2586> and Solegia Pharma <4597> were dominated by selling pressure.

There is a possibility that individual stocks will be actively searched based on investor sentiment, and there is only one IPO.

Next week's emerging market is likely to take a breather. In the prime market, the Nikkei Average is facing resistance around the 38,000 yen level. This level has high volume in terms of trade by price range, suggesting strong selling pressure waiting for a rebound. The growth market 250 index has returned to the level of August 1st before the sharp drop, so like the prime market, there is a situation where selling pressure waiting for a rebound is likely to occur in the emerging market. The trading volume is slightly less than 100 billion yen, and trading activity is not significantly expanding. Investors focusing on high dividend stocks and stocks with special benefits in the prime market in anticipation of the September market may be a factor in the lack of growth in trading volume. We need trading volume that can absorb selling pressure waiting for a rebound.

However, the search for low-priced stocks through the process of elimination has subsided, and investor sentiment remains positive as large-cap stocks continue to rise. There is ample room for the search for stocks with high themes such as bio-related and space-related stocks to intensify. In the bio-related sector, there is a possibility that cyclic trading will shift to Chordia Therapeutics <190A> and Perseus Proteomics <4882>, which declined this week. In addition, if QPS Institute <5595>, a space-related company, exceeds the 25-day moving average, there is a mood for a sudden move. Although the upside of the index in the emerging market is expected to be heavy, there is a possibility that individual stock searches will broaden based on investor sentiment.

On August 29th, Cross E Holdings <231A>, which is involved in the construction of facilities such as Huis Ten Bosch and public facilities, as well as incinerators and resource recycling facilities, will be listed on the Fukuoka Q-Board market. It may not attract much attention as a listing only on a local market, but the interest may shift to waste disposal companies due to reports that the Ministry of the Environment is seeking a tax reduction for corporate taxes for waste disposal operators, which caused a sharp rise in Linet Japan Group <3556> over the weekend.